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cardiomyocyte maturation by serum response
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After birth, cardiomyocytes (CM) acquire numerous adaptations in order to efﬁciently pump
blood throughout an animal’s lifespan. How this maturation process is regulated and coor-
dinated is poorly understood. Here, we perform a CRISPR/Cas9 screen in mice and identify
serum response factor (SRF) as a key regulator of CM maturation. Mosaic SRF depletion in
neonatal CMs disrupts many aspects of their maturation, including sarcomere expansion,
mitochondrial biogenesis, transverse-tubule formation, and cellular hypertrophy. Main-
tenance of maturity in adult CMs is less dependent on SRF. This stage-speciﬁc activity is
associated with developmentally regulated SRF chromatin occupancy and transcriptional
regulation. SRF directly activates genes that regulate sarcomere assembly and mitochondrial
dynamics. Perturbation of sarcomere assembly but not mitochondrial dynamics recapitulates
SRF knockout phenotypes. SRF overexpression also perturbs CM maturation. Together, these
data indicate that carefully balanced SRF activity is essential to promote CM maturation
through a hierarchy of cellular processes orchestrated by sarcomere assembly.
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Adult cardiomyocytes (CMs) generate forceful contractionsbillions of times during the lifespan of an adult human.Specialized features that adapt CMs for this unique
activity include their large rod-like shape, nearly crystalline sar-
comere organization, robust oxidative metabolic capacity,
expression of mature sarcomere gene isoforms, exit from the cell
cycle, and an extensive network of transverse tubules (T-tubules),
which are plasma membrane invaginations that facilitate syn-
chronized calcium release1,2. In contrast to adult CMs, these
specialized features are absent or underdeveloped in fetal and
neonatal CMs, which are smaller, proliferative, glycolytic cells
with less organized sarcomeres, fewer and smaller mitochondria,
and no T-tubules. The dramatic transition between fetal and adult
phenotypes, termed CM maturation, occurs in the ﬁrst few weeks
following birth (approximately P0–P21) in mice. Little is known
about the signals and transcriptional machineries that coordinate
CM maturation. Likewise, it is unclear if the maintenance of
maturity is regulated by the same or distinct mechanisms.
Understanding CM maturation is critical to answering many
major questions in cardiac biology. Because CM maturation is
essential to establish proper heart functions in adults, aberrations
in CM maturation could result in or exacerbate cardiomyo-
pathies. Maturation may also be disturbed by abnormal hemo-
dynamic loads due to congenital heart malformation, which may
impact outcomes in congenital heart disease patients. CM
maturation is associated with the loss of CM regeneration capa-
city, which occurs in the ﬁrst week after birth in mice3. CM de-
maturation, often referred as CM dedifferentiation, is likely to be
important for CM regeneration3–5. Finally, improved under-
standing of normal CM maturation mechanisms is required for
us to better harness the therapeutic potential of stem cell-derived
CMs, which is currently limited by our inability to mature them1.
CM maturation studies have been held back by technical
challenges. Because fully mature CMs cannot be induced or
maintained in in vitro cell culture systems, these approaches are
not ideal to study CM maturation. Progress using in vivo models
has been slow and expensive, due to the time required to produce
and mate genetically modiﬁed mouse models for each candidate
gene. Moreover, studies in mice with organ-wide gene mod-
iﬁcations have been confounded by secondary effects, such as the
de-maturation-like phenotypes of heart failure6. We recently
established an adeno-associated virus (AAV)-mediated CRISPR/
Cas9-based somatic mutagenesis system (CASAAV) that pro-
vided a robust platform to study CM maturation in vivo6,7
(Supplementary Fig. 1a). CASAAV allows quick generation of
loss-of-function mutations of a given gene speciﬁcally in neonatal
CMs. Importantly, through AAV titration, this method can easily
generate genetic mosaics6,8, which allows cell-autonomous gene
functions to be probed while circumventing the confounding
secondary effects of organ-wide dysfunction.
In this study, we perform a CASAAV-based screen and iden-
tiﬁed serum response factor (Srf) as a key regulator of CM
maturation. Genetic mosaic analysis of SRF depletion and over-
expression show that SRF is a stage-speciﬁc, dosage-sensitive
regulator of CM maturation. Furthermore, we identify a hierarchy
of maturation processes, in which sarcomere maturation was
required for morphological maturation but mitochondrial bio-
genesis was not.
Results
CASAAV-based screen for T-tubule maturation factors in vivo.
Reasoning that CM maturation may be regulated by factors that
also regulate CM differentiation, we studied nine transcriptional
regulators of CM differentiation (Gata4, Gata6, Mef2a, Mef2c,
Tead1, Srf, Tbx5, Nkx2.5, and Tead1) as candidate maturation
factors (Supplementary Fig. 1b). We performed CASAAV-based
mutagenesis of each factor in postnatal day 1 (P1) CMs and
assessed the impact on T-tubule formation in 1-month-old
hearts. In situ T-tubule imaging and quantitative analysis by
AutoTT9, a software that objectively quantiﬁes T-tubule contents
by normalizing T-tubule patterns to cell morphology6,9,10,
revealed that AAV directed against Srf was the only treatment
that caused T-tubule defects (Supplementary Fig. 1c, d). Among
the remaining candidates, we had previously validated effective
GATA4, NKX2-5, and TEAD1 CASAAV-mediated depletion6,7.
Here we also validated successful depletion of SRF and GATA6
by CASAAV (Supplementary Fig. 1e, f), and we conﬁrmed the
dispensable role of TBX5 in T-tubule formation using a well-
established Tbx5-ﬂoxed allele11 (Supplementary Fig. 1g). Toge-
ther, these data demonstrate a unique role of Srf in CM
maturation.
Genetic mosaic SRF depletion in CMs. Ablation of Srf by con-
ventional conditional knockout (KO) technologies causes lethal
dilated cardiomyopathy12–14, which generates secondary effects
of heart stress that confound analysis of SRF functions in phy-
siological conditions, such as CM maturation. To solve this
problem, we used an AAV vector (AAV-cTNT-Cre, or AAV-Cre)
6,15 to speciﬁcally deliver Cre recombinase into CMs in mice with
well-characterized ﬂoxed Srf alleles (SrfF/F)12. Injection of a high
(1 × 1010 vg g−1) or intermediate (5 × 109 vg g−1) dose of AAV-
Cre into P1 SrfF/F mice triggered lethality and acute cardiomyo-
pathy characterized by heart failure, ventricular dilatation,
ﬁbrosis, and the up-regulation of cardiac stress markers Nppa and
Nppb (Fig. 1a–d). This is consistent with previous ﬁndings that
Srf is essential for proper heart function13,16,17. We next titrated
down the dose of AAV-Cre to 5 × 108 vg g−1, which generated
mosaic Srf inactivation in <15% CMs while maintaining normal
heart morphology and function (Fig. 1a–d). This mosaic KO
strategy opens the door to study the cell-autonomous role of Srf
in CM maturation while minimizing confounding effects of heart
dysfunction.
We generated SrfF/F;RosaFP/FP (KO) and SrfF/+;RosaFP/FP
(control (CTRL)) mice that harbored Cre-inducible ﬂuorescent
protein (FP) reporters (either Cas9GFP, tdTomato, or mTmG, see
Fig. 1e), which were essential to identify and purify Cre-activated
CMs in the mosaics. Comparison of SRF immunostaining to FP
expression in SrfF/F;RosaFP/FP mice indicated that 85–90% of FP+
CMs lacked SRF, compared to only 10% of FP− CMs (Fig. 1e).
Quantitative reverse transcription-polymerase-chain reaction
(RT-qPCR) and RNA-sequencing (RNA-seq) analyses of FP+
CMs that were puriﬁed by ﬂow cytometry (ﬂuorescence-activated
cell sorting (FACS)) indicated ~60% Srf depletion in SrfF/F CMs
as compared to SrfF/+ CMs (Fig. 1f). This efﬁciency was slightly
lower than the anticipated 85–90% accuracy of the FP reporters as
determined by immunostaining (Fig. 1e), which likely reﬂects
imperfect FACS performance in sorting large CMs. These data
indicated that FP reporters were useful surrogate markers to
identify and enrich AAV-Cre-infected CMs.
Stage-speciﬁc role of SRF in CM maturation. We ﬁrst analyzed
the impact of SRF depletion on key morphological hallmarks of
maturation in actively maturing CMs by injecting AAV-Cre into
P1 mice (neonatal KO) and analyzing 1 month later. Consistent
with the CASAAV-based loss-of-function screen (Supplementary
Fig. 1d, e), neonatal Srf KO caused dramatic T-tubule loss in FP+
SrfF/F CMs as compared to FP− CTRLs (Fig. 2a). This result was
further validated by immunoﬂuorescent staining of key T-tubule
markers JPH2 and CAV3 on isolated CMs (Supplementary
Fig. 2a). In situ imaging revealed decreased CM size (Fig. 2a) in
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neonatal Srf KO CMs, which was conﬁrmed by measuring CM
cross-sectional area (Supplementary Fig. 2b). ACTN2, a sarco-
mere Z-line marker, retained a grossly normal, striated sarcomere
pattern in SRF-depleted CMs, although aberrant longitudinal
ACTN2 localization could be observed between some Z-lines (red
arrows in Fig. 2b). The distance between Z-lines also decreased in
mutant CMs (Fig. 2b). We next FACS-sorted FP+ CMs and
performed electron microscopy (EM; Supplementary Fig. 2c),
which conﬁrmed grossly normal myoﬁbrillar striations in FP+
SrfF/F CMs and uncovered a signiﬁcant reduction of myoﬁbril
numbers as compared to FP+ SrfF/+ CMs (Supplementary
Fig. 2d). EM also revealed loss of the M-line, a hallmark of
maturation, and the formation of bulged Z-lines (Supplementary
Fig. 2e), which were consistent with the longitudinal
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Fig. 1Mosaic knockout of Srf circumvents disruption of global heart function. a Survival curve of SrfF/F;RosaFP/FP mice treated with low, mid, and high doses
of AAV-Cre at P1. b Effect of AAV-Cre dosage on heart function and chamber size at P30. Left ventricle (LV) function and size were assessed
echocardiographically by measuring the LV fractional shortening (FS) and internal diameter at end systole (LVID;s) and diastole (LVID;d). n= 5 per group.
c Effect of AAV-Cre doses on myocardial ﬁbrosis. Fibrosis was measured from heart sections stained with sirus red (top) or wheat germ agglutinin (WGA,
bottom). The fraction of FP+ cells in heart sections was quantiﬁed and labeled in white. d RT-qPCR analysis of cardiac stress marker expression from heart
ventricles. n= 4 per group. e Representative images of SRF immunoﬂuorescence in FP+ and FP− SrfF/F;RosaFP/FP CMs that were isolated from the same
heart. Arrows point to SRF-FP+ nuclei. Quantiﬁcation was shown to the right. n= 3 hearts. f Representative FACS plots and gating to sort FP+ CMs (left)
and measurement of Srf expression in FACS-sorted FP+ CMs (right) by RT-qPCR and RNA-seq. AAV-Cre was injected at P1 and CMs analyzed at P14, or
AAV-Cre was injected at P60 and CMs analyzed at P90. n= 3 hearts. Bar plots show mean ± SD and are overlaid by dot plots of individual data. Two-tailed
Student’s t test: *P < 0.05, ***P < 0.001. F/+: SrfF/+. F/F, SrfF/F. Scale bar, 20 µm
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ACTN2 staining observed in SRF-depleted CMs (Fig. 2b). Geo-
metric analysis of isolated CMs showed that Srf ablation dra-
matically decreased projected cell area and cell width, but cell
length was only slightly reduced, resulting in strikingly increased
length:width ratio (Fig. 2c). Thus, hypertrophic growth of
maturing CMs is blocked in the absence of SRF. Terminal
deoxynucleotidyl transferase dUTP nick-end labeling
(TUNEL) analyses did not label Srf KO CMs, suggesting that their
severe phenotypes are not due to cell death (Supplementary
Fig. 2f).
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To assess the role of Srf in the maturation of CM physiological
activity, we next assayed CM contractility and Ca2+ transients
following neonatal SRF depletion. Bright-ﬁeld live imaging of
electrically paced CMs was performed to measure sarcomere
contraction and relaxation18 (Supplementary Fig. 3a). In mutant
cells, we observed dramatically lower sarcomere fractional
shortening and relaxed sarcomere length (Fig. 2d), consistent
with sarcomere measurements made in ﬁxed and relaxed CMs
(Fig. 2b). In contrast, contracted sarcomere length was preserved
in mutant CMs (Fig. 2d). We also tested Ca2+ handling by
recording confocal line scans of electrically paced CMs loaded
with the Ca2+-sensitive dye Fluo-4 (when FP was tdTomato) or
Rhod-2 (when FP was Cas9GFP). The mutant cells displayed
reduced Ca2+ transient amplitude and prolonged time to peak
Ca2+ signal (Supplementary Fig. 3b), consistent with the T-tubule
defects (Fig. 2a). Together, these data show that Srf is essential for
functional maturation of CMs, in part through its role in
morphological maturation.
SRF depletion could trigger the above phenotypes through
either perturbation of a speciﬁc CM maturation program or
disruption of the maintenance (or homeostasis) of CM maturity.
To distinguish these two mechanisms, we next injected AAV-Cre
into adult (P60) animals to induce adult-speciﬁc Srf inactivation
in CMs (adult KO). RT-qPCR and RNA-seq revealed similar Srf
depletion efﬁciencies between neonatal and adult KO models
(Fig. 1f). Strikingly, adult-speciﬁc depletion of SRF in CMs
resulted in minor defects in T-tubule organization (Fig. 2e),
sarcomere organization (Fig. 2f), and CM area, length, width, and
length:width ratio (Fig. 2g). Adult KO did not change relaxed
sarcomere length (Fig. 2h) or time to peak Ca2+ signal
(Supplementary Fig. 3b) in electrically paced CMs. However,
adult KO did reduce CM fractional shortening as a result of
increased contracted sarcomere length (Fig. 2h), and decreased
Ca2+ transient amplitude (Supplementary Fig. 3b). Together,
these data demonstrate a profound and stage-speciﬁc role of Srf in
CM maturation.
Stage-speciﬁc transcriptomic regulation by SRF. To determine
the mechanisms by which Srf regulates CM maturation, we
proﬁled transcriptome changes in both neonatal and adult SRF
KO models by RNA-seq. In the neonatal KO model, AAV-Cre
was delivered at P1, and CMs were analyzed at P14. In the adult
KO model, AAV-Cre delivery and CM analysis occurred at P60
and P90, respectively. In both models, SrfF/F (KO) and SrfF/
+(CTRL) FP+ CMs were FACS-puriﬁed before RNA extraction;
RNA-seq libraries were prepared using a protocol designed for
low RNA input (Fig. 3a)19. Principal component analysis (PCA)
showed clear separation between CTRL and KO groups in both
neonatal and adult models (Supplementary Fig. 4a). We identiﬁed
999 down-regulated genes and 787 up-regulated genes in neo-
natal Srf KO (adjusted P value <0.05; Supplementary Fig. 4b). By
contrast, using the same statistical threshold, adult Srf KO only
caused down-regulation and up-regulation of 164 and 148 genes,
respectively (Supplementary Fig. 4b). PCA better separated CTRL
and KO in neonatal as compared to adult stage (Fig. 3b). The
differentially expressed genes were weakly correlated (r= 0.426;
Fig. 3c) between neonatal and adult stages. Only 6.2% of all
down-regulated genes (68 genes) were down-regulated in both
models (Fig. 3d). Thus, Srf regulates transcription in a
maturation-speciﬁc manner.
We performed gene set enrichment analysis (GSEA)20 to
identify the major biological processes downstream of Srf. In the
neonatal KO model, the major gene ontology (GO) terms
enriched among down-regulated genes were related to oxidative
phosphorylation and mitochondria (Fig. 3e). Key regulators of
mitochondrial biogenesis (Ppargc1b, Rxrg), mitochondria
dynamics (mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), Opa1), and
mitochondrial transcription (Tfam, Tfb1m) were down-regulated
upon neonatal KO (Fig. 3f). Upstream regulator analysis by
Ingenuity Pathway Analysis (IPA) also identiﬁed key mitochon-
drial biogenesis regulators Insr, Ppargc1a, and Esrra (Supple-
mentary Fig. 4c). The profound role of SRF in mitochondria and
respiration in the neonatal KO model is striking, because this was
not noted in previously reported models where disrupting Srf
signaling mainly disrupts genes related to heart development and
the sarcomere/actin cytoskeleton12,14,21–24. Indeed, heart devel-
opment and muscle cell differentiation were the major down-
regulated GO terms in adult Srf KO models (Supplementary
Fig. 4d); mitochondria-related and metabolism-related genes
were not enriched in adult Srf KO (Fig. 3e, f). These data indicate
a unique stage-speciﬁc role of Srf in mitochondrial and metabolic
maturation.
To further validate the role of Srf in mitochondrial
maturation, we performed EM on neonatal Srf KO and CTRL
CMs (Supplementary Fig. 5a, b). We observed a dramatic
reduction of mitochondrial size and number in the Srf KO cells.
Mitochondrial DNA, transcription, and protein components
were also decreased in FACS-sorted FP+ SrfF/F CMs (Supple-
mentary Fig. 5c–e). However, in situ imaging of CMs that were
labeled by tetramethylrhodamine (TMRM), a mitochondrial
membrane potential indicator, was unperturbed in FP+ SrfF/F
CMs, suggesting retained mitochondria quality in neonatal Srf
KO CMs (Supplementary Fig. 5f).
We next examined the expression of genes regulating
sarcomere assembly and Ca2+ handling. Strikingly, in contrast
to an expected down-regulation of most sarcomere genes21, we
observed both up-regulation and down-regulation of sarcomere
genes (Fig. 3g). Down-regulation of core sarcomere components
such as Actc1, Myh6, and Myl3 explained the sarcomere assembly
defects in neonatal KO model (Fig. 2b). The up-regulation of Z-
line components Actn2, Tcap, and Csrp3 (Fig. 3g) was consistent
with the excessive Z-line patterns found in neonatal KO model
(Fig. 2b). These genes were also differentially expressed in the
adult KO model where there was no detectable sarcomere
disorganization (Fig. 2f), which suggested that the abundance of
Fig. 2 Srf plays a profound role in CM maturation but not the maintenance of CM maturity. a–d Mosaic depletion of Srf in neonatal CMs in vivo resulted in
dramatic defects in T-tubule organization (a), sarcomere organization (b), maturational hypertrophic growth (c), and contraction (d). e–h Srf ablation in
adult CMs had a minor impact on T-tubule organization (e), sarcomere organization (f), maturational hypertrophic growth (g), and contraction (h). a, e
Representative in situ images of T-tubules that were labeled by membrane dye FM 4–64 and quantiﬁed by the AutoTT software9. Scale bar, 20 μm. b, f
Confocal images of ACTN2-immunostained isolated CMs, demonstrating organization of sarcomere z-lines. Red arrowheads point to abnormal
ACTN2 staining that extends between z-lines. Regularity was measured by AutoTT and Z-line spacing measured manually. c, g Quantiﬁcation of the size
and morphology of isolated CMs. d, h Measurement of CM contractility. Isolated CMs were paced at 1 Hz. Bright-ﬁeld images were acquired and then
analyzed using SarcOptiM18. In violin plots, white circles show the medians, box limits indicate the 25th and 75th percentiles, whiskers extend 1.5 times the
interquartile range from the 25th and 75th percentiles, and polygons represent density estimates of data and extend to extreme values. Two-tailed
Student’s t test: *P < 0.05, **P < 0.01, ***P < 0.001. Non-signiﬁcant P values are labeled within parentheses
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these sarcomere gene transcripts is not limiting for maintenance
of sarcomere organization in adult CMs. Notably, mature
myoﬁbrillar isoforms, including Myh6, Tnni3, Myl2 and Myl3,
were down-regulated in neonatal Srf KO CMs, and the
corresponding immature isoforms, Myh7, Tnni1, Myl7, and
Myl4, were up-regulated (Fig. 3g, highlighted genes). This
strongly suggests a key role of Srf in myoﬁbrillar isoform
switching, a critical transcriptional maturation hallmark1. We
also observed down-regulation of Atp2a2, Slc8a1, Ryr2 and up-
regulation of Cacna1c (Fig. 3h), which likely contributed to Ca2+
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handling defects in addition to the T-tubule phenotypes.
Interestingly, we observed up-regulation of Hcn4 (Fig. 3h), an
ion channel that is speciﬁcally expressed in immature CMs25.
Selective chromatin binding by SRF in maturing CMs. In order
to map SRF chromatin occupancy, we generated a knock-in allele
of Srf that was fused to a biotin acceptor peptide (BIO tag) at the
carboxyl-terminus (Srffbio; Supplementary Fig. 6a). BIO is speci-
ﬁcally biotinylated by the Escherichia coli biotin ligase BirA,
which was expressed from the Rosa26BirA allele26. In hearts
containing both alleles, SRF was biotinylated so that it could be
efﬁciently pulled down on immobilized streptavidin (Fig. 4a and
Supplementary Fig. 6b). This system allowed us to pull-down
SRF-associated chromatin in the heart in a highly sensitive and
speciﬁc manner, circumventing the caveats of antibody-based
chromatin immunoprecipitation27. We performed next-
generation sequencing of SRF co-precipitated DNA (bioChIP-
seq) and identiﬁed SRF binding sites in the genome. At P14 and
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adult stages, we obtained two biological replicates of SRF
bioChIP-Seq data. There was very high correlation (r > 0.95)
between biological repeats (Fig. 4b and Supplementary Fig. 6c, d).
The SRF DNA-binding motif (the CArG motif) was the top
sequence recovered by de novo motif ﬁnding (Supplementary
Fig. 7a), which further validated the efﬁcacy of this method.
BioChIP-seq identiﬁed 31,301 and 6792 high-conﬁdence (P <
1 × 10−5) peaks at P14 and adult stages, respectively (Supple-
mentary Fig. 6c). Among all SRF-bound regions found at P14,
24,695 (78.9%) were uniquely identiﬁed at P14 and termed
maturation-speciﬁc SRF-bound elements (MEs) (Fig. 4a). By
contrast, 6606 (21.1%) of P14 regions were also identiﬁed in adult
CMs. These constitutive SRF-bound elements (CEs; Fig. 4a)
composed 97.3% of adult SRF-bound regions. Interestingly, SRF
elements with the highest occupancy signal were most likely to be
retained in adult heart at CEs, with 83% of the P14 regions in the
highest SRF occupancy signal decile being CEs (Fig. 4b and
Supplementary Fig. 7b). However, genes regulating major heart
functions such as heart development, myoﬁbril assembly, and
metabolism were more enriched neighboring MEs compared to
CEs (Fig. 4c). Together, these data indicate that postnatal CM
maturation is accompanied by loss of developmental SRF binding
to chromatin, which likely explains SRF maturation-speciﬁc
transcriptional regulation (Fig. 3).
We further characterized the properties of MEs compared to
CEs. Analysis of the location of SRF sites with respect to
transcriptional start sites (TSSs) showed that more than 20% of
MEs and more than 60% of CEs are proximal to promoters.
Considering that promoters occupy <1% of the genome, these
data represent substantial enrichment of SRF occupancy near
promoters for both MEs and CEs. As compared to CEs, more
MEs are distal to promoters (TSS ± 1000 bp) (Fisher’s exact test:
P < 10−16; Fig. 4d). We also performed motif analysis on
proximal or distal CEs and MEs with the strongest SRF
occupancy signal (top 1000 per group; Fig. 4e). MEs and CEs
showed a similar overall motif enrichment pattern when
compared to randomly permuted background. However, different
sets of motifs were enriched in proximal vs. distal regions.
Enriched distal co-motifs included MEF2, GATA, and TEAD,
whereas enriched proximal co-motifs included MEF2, SP1, KLF,
and ETS (Fig. 4e). Consistent with these data, physical interaction
of SRF with GATA, TEAD, KLF, and ETS family proteins has
been reported previously28–31. An analysis of differential motif
enrichment between MEs and CEs showed that both proximal
and distal CEs were more enriched for the SRF motif than MEs.
Distal MEs were signiﬁcantly more enriched for MEF2 and
GATA motifs. Consistent with this observation, SRF binding sites
in P14 hearts overlapped with 35% GATA4 binding sites and 37%
MEF2A binding sites that were previously identiﬁed by ChIP-seq
in the HL1 cardiac muscle cell line27 (Supplementary Fig. 7c).
These ﬁndings imply that SRF collaboration with MEF2 and
GATA family members is a potential mechanism that regulates
CM maturation.
Next, we evaluated the relationship between P14 and adult
chromatin occupancy and differential gene expression. Genes
down-regulated in neonatal but not adult SRF KO were deﬁned as
maturation-speciﬁc Srf-regulated genes (MGs), and genes down-
regulated in both models were deﬁned as constitutively Srf-
regulated genes (CGs). A large majority of both MGs (657 of 931,
70.5%) and CGs (46 of 68, 67.6%) neighbored an SRF-bound
region, suggesting that they were directly activated by Srf. We
noted that mature sarcomere isoforms Myh6, Myl3, Myl2, and
Tnni3 were highly down-regulated in Srf KO, whereas their
immature counterparts (Myh7, Myl4, Myl7, and Tnni1) were not
(Fig. 3g). Interestingly, these four mature sarcomere isoform
genes, but not their immature paralogs, were associated with
strong SRF occupancy near their promoters (Fig. 4f). We
investigated more broadly the relationship of SRF occupancy
signal and TSS distance to differential gene expression. For MGs,
both SRF occupancy signal and proximity to TSS were associated
with the fraction of adjacent genes that were down-regulated with
Srf KO; indeed, 78.2% (514/657) of all SRF-regulated MGs had
SRF binding in the top six deciles and within 10 kb of the TSS
(Fig. 4g). By contrast, this relationship was not observed for up-
regulated genes (Supplementary Fig. 7d). Together, these data
suggest that the widespread loss of SRF occupancy and reduction
of SRF binding strength during CM maturation directly
contribute to the maturation speciﬁcity of SRF-mediated
transcriptional regulation.
Hierarchical regulation of CM maturation by SRF. To connect
SRF-based transcriptional regulation with morphological and
functional phenotypes that were observed in SRF-depleted cells
(Fig. 2), we next studied the roles of direct SRF downstream genes
in CM maturation. Mitochondrial fusion regulators Mfn1/2 are
essential for heart development at perinatal stages32. SRF bound
to both proximal and distal regions near Mfn1/2 in a maturation-
speciﬁc manner (Fig. 5a). In the neonatal Srf KO model, Mfn1
and Mfn2 were down-regulated (Fig. 3f) and mitochondrial size
decreased (Supplementary Fig. 5a), a typical phenotype of
defective mitochondrial fusion. Therefore, we hypothesized that
Mfn1/2 were direct SRF targets that played a key role in CM
maturation.
To probe the cell-autonomous contribution of Mfn1/2 on
CM maturation, we inactivated Mfn1/2 in a small fraction
(~15%) of CMs by injecting low-dose AAV-Cre-P2A-GFP
(CRE) or AAV-GFP (CTRL) into P1 Mfn1F/F;Mfn2F/F;Rosamt-
Dendra2 mice (Fig. 5b), which harbored well-characterized ﬂoxed
alleles of Mfn1/233. FACS-sorted AAV-transduced Dendra/GFP
+ CMs exhibited depletion of Mfn1 and Mfn2 RNA and protein
in the CRE group compared to CTRL group (Fig. 5c).
Mitochondria fusion defects in the mutant CMs were further
validated by decreased mitochondria size through EM analysis
(Fig. 5d). Surprisingly, MFN1/MFN2-depleted CMs exhibited
very mild T-tubule disorganization and no detectable disrup-
tion of TMRM labeling, sarcomere organization, cell size, or
shape (Fig. 5e–h). To further conﬁrm this result, we over-
expressed DRP1, a key activator of mitochondrial ﬁssion34,
through AAV-based gene transfer in neonatal CMs (Supple-
mentary Fig. 8a, b). This approach up-regulated DRP1 by more
than 10-fold (Supplementary Fig. 8c) and decreased mitochon-
dria size (Supplementary Fig. 8d). Despite these strong
perturbations to mitochondrial dynamics and morphology, we
observed very mild effects on mitochondria membrane
potential, T-tubule formation, sarcomere organization, cell
size, and shape (Supplementary Fig. 8e–h). These ﬁndings are
consistent with our recent study of Tfam35, a critical
mitochondrial transcription factor that was down-regulated
upon SRF depletion (Fig. 2f), as well as a recent DRP
overexpression study using transgenic mice36. The striking
difference between our mosaic analyses and previous organ-
wide ablation of Mfn1/2 in CMs suggests that secondary effects
of heart failure confounded studies of organ-wide Mfn1/2
cardiac KO32. Together, our data indicate a minor role of
mitochondrial dynamics in other aspects of CM maturation.
Another key facet of CM maturation downstream of Srf was
sarcomere assembly. Therefore, we next probed the contribution
of sarcomere assembly to overall CM maturation. We inactivated
Myh6, a direct Srf target (Figs. 3g and 4f) that composed the
majority of myosin heavy chains in mature myoﬁbrils, by
CASAAV. At P1, we delivered the CASAAV virus, containing
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two gRNAs targeting Myh6 sites separated by 79 bp, to
RosaCas9GFP mice (Fig. 6a). This resulted in detectable deletion
of the 79 bp fragment (Fig. 6a). We titrated the dose to achieve
mosaic MYH6 ablation without impacting heart contraction.
Depletion of Myh6 mRNA and protein was further validated by
FACS-RT-qPCR and immunostaining, respectively (Fig. 6b, c).
MYH6 ablation caused complete disassembly of sarcomeres
(Fig. 6d) as well as dramatic defects in maturational hypertrophy,
T-tubulation, and mitochondrial organization (Fig. 6e–g).
Together, these data show that sarcomeres are core organizers
of other aspects of CM maturation. The diverse CM maturation
events are orchestrated in a hierarchical manner that requires
myoﬁbrillar maturation.
Balanced SRF activity is essential for CM maturation. Given the
profound impact of Srf on CM maturation, we wondered whether
activating Srf was sufﬁcient to promote CM maturation. To
answer this, we overexpressed SRF in neonatal CMs through
mosaic AAV-mediated gene delivery (Fig. 7a). GFP over-
expression was used as CTRL. This approach up-regulated Srf by
~8-fold in transduced CMs, as measured by FACS-RT-qPCR.
Nuclear accumulation of SRF was validated by immuno-
ﬂuorescence (Fig. 7b). Strikingly, SRF overexpression dramati-
cally disrupted T-tubule formation, maturational hypertrophy,
sarcomere organization, and mitochondria distribution
(Fig. 7c–f).
We next analyzed transcriptomic changes by administering a
mosaic dose of either AAV-SRF-P2A-GFP or AAV-GFP,
purifying transduced GFP+ CMs by FACS and then performing
RNA-seq. SRF overexpression up-regulated 1285 genes (Fig. 8a).
Interestingly, very few of these genes (1.7%) overlapped with
genes down-regulated by SRF KO (Fig. 8b). By GSEA analysis,
vasculature development and angiogenesis were the major up-
regulated GO terms in SRF overexpressing CMs (Fig. 8c).
Consistent with this observation, the up-regulated genes included
markers of endothelial cells, smooth muscle cells, and ﬁbroblasts
(Fig. 8d). Through an independent IPA analysis, we also
identiﬁed the activation of inﬂammatory signaling pathways
involving transforming growth factor-β1, interferon-γ, tumor
necrosis factor, and interleukin-6. (Fig. 8e). Thus, SRF over-
expression causes ectopic gene activation that should not be
b c
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present in maturing CMs. Furthermore, SRF overexpression
caused dramatic down-regulation of metabolism and myoﬁbril
genes (Fig. 8f, g), which explained the defects in morphological
maturation (Fig. 7). Together, these data indicate that SRF activity
must be carefully balanced for proper CM maturation.
Discussion
CM maturation is one of the least understood processes in heart
development. In this study, we performed a CRISPR/Cas9-based
screen in mice and identiﬁed SRF as a transcriptional regulator that
orchestrated almost every aspect of CM maturation. Using SRF as a
model molecule, we uncovered several critical principles that govern
CM maturation (Fig. 9): First, SRF regulated maturation only in
actively maturing, neonatal CMs through stage-speciﬁc chromatin
occupancy and transcriptional control. This implies the presence of a
unique, maturation-speciﬁc transcriptional regulation network that
was not recognized previously. Second, we showed that SRF sig-
naling needs to be tightly balanced for proper maturation. Both
hypo-activation and hyper-activation of SRF resulted in severe
transcriptional dysregulation that impacted sarcomere and mito-
chondria maturation. Third, the diverse maturation processes
downstream of SRF appear to be orchestrated in a hierarchical
manner. That sarcomere inactivation was sufﬁcient to impair mul-
tiple facets of CM maturation suggests that myoﬁbrillar maturation
is a dominant and essential process, and that sarcomeres are
core organizers of other aspects of CM maturation. However, our
data do not exclude additional direct roles of SRF in other
aspects of maturation, such as mitochondrial maturation.
Overall, this report provides direct demonstration of an essential
a
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and central role of sarcomeres in organizing the diverse programs of
CM maturation.
The new information acquired in this study provides potential
guidance to mature stem cell-derived CMs. For example, bio-
mechanical environments are known to inﬂuence the maturation
of CMs in vitro. Speciﬁcally, an intermediate stiffness of cell
culture matrix, mimicking the native mechanical environment,
was reported to be essential for CM maturation37,38. SRF is a
well-established effector of mechanotransduction signaling in
response to matrix stiffness39,40; thus, an intermediate matrix
stiffness might promote CM maturation by establishing an
intermediate level of SRF activity. In addition, sarcomere disarray
is a common phenotype that is observed in CMs cultured in a
monolayer on an unpatterened substrate. Culture on micro-
patterned substrates41–43 or within three-dimensional substrates
with directional tension44–47 improve sarcomere organization.
Our results demonstrate that organized sarcomere assembly is a
key organizer on top of the hierarchy of other CM maturation
processes. These results indicate that sarcomere organization
achieved by these engineered environments is essential to
enhance all other aspects of CM maturation, and that optimiza-
tion of SRF signaling and sarcomere organization are likely to be
key mechanisms by which bioengineering approaches improve
maturation of stem cell-derived CMs. These insights promise to
allow us to use rationale approaches to further optimize the
maturation of stem cell-derived CMs.
SRF is a well-established cardiac TF that has been studied for
more than a decade in the heart. However, prior studies used
traditional conditional KO strategies that cause acute lethality and
cardiomyopathy12–14,16,48. As a result, the critical role of SRF in
CM maturation was overlooked. Here we establish AAV-based
genetic mosaic analyses as a key strategy to minimize con-
founding secondary effects of heart dysfunction. This generated
new information that signiﬁcantly updated our prior under-
standing of the function of SRF in CMs. For example, although
we observed sarcomere defects that agreed with SRF’s previously
established function, neonatal and mosaic SRF KO exhibited
grossly normal striated myoﬁbril patterns—a much milder phe-
notype than previously reported in SRF-depleted developing
hearts12,48. Prior studies found that SRF was required to activate
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transcription of both mature and immature sarcomere compo-
nents21. However, here we demonstrated a selective role of SRF in
activating only mature, but not immature, sarcomere isoforms. In
addition, we found dramatic down-regulation of GO terms rela-
ted to mitochondria and metabolism, but not heart development
or muscle cell differentiation, in neonatal mosaic Srf KO. This
profound role of SRF in mitochondria and metabolism was not
observed in previous studies, likely due to both acute lethality that
precluded study of Srf at the neonatal stage and to obfuscating
effects of heart failure. Likewise, the mosaic strategy allowed us to
circumvent lethality caused byMyh6 disruption and thereby hone
in on the essential function of sarcomeres to promote CM
maturation.
Our genetic mosaic analysis also challenges the established
paradigm of mitochondrial dynamics in heart development. We
observed minimal morphological phenotypes upon mosaic
MFN1/2 depletion or DRP1 overexpression in neonatal CMs.
This ﬁnding contrasts sharply with the dramatic heart phenotypes
of conventional organ-wideMfn1/2 double KOs32,49. This is likely
due to secondary effects of heart dysfunction that ampliﬁed the
severity of the phenotypes in previous Mfn1/2 double KOs,
although we cannot rule out the possibility that Mfn1/2 are
required for CM maturation at an earlier embryonic stage, or that
the kinetics of Mfn1/2 inactivation in our system missed a critical
time window necessary to observe the more dramatic effects that
were previously reported. This study, together with previous
studies of Tfam35 and Drp136, indicates a relatively minor role of
normal mitochondria function in promoting CM maturation.
Methods
Mouse strains. All animal strains and procedures were approved by the Institu-
tional Animal Care and Use Committee of Boston Children’s Hospital.
RosaCas9GFP/Cas9GFP(Jackson Lab Stock No.: 026175)50, RosaTomato/Tomato
(Jackson Lab Stock No.: 007914)51, RosamTmG/mTmG(Jackson Lab Stock No.:
007576)52, and RosaBirA/BirA (Jackson Lab Stock No.: 010920)26 were imported
from the Jackson Laboratory. SrfF/F12 (Jackson Lab Stock No.: 006658), Mfn1F/F;
Mfn2F/F;RosamtDendra2 33,53 (Jackson Lab Stock No.: 026401, No.: 026525, and No.:
018385), and Tbx5F/F 11 mice were kind gifts from the labs of Joe Miano, David
Chan, and Ivan Moskowitz. All mice were on a mixed genetic background.
Srffbio mice were generated by homologous recombination in ES cells (Extended
Data Fig. 6a). A targeting vector containing homology arms, the FLAG-BIO
epitope tag fused to the 3′ end of SRF, and an Frt-Neo-Frt selection cassette was
used to generate targeted ES cells. Blastocyst injection yielded chimeric mice.
Germline transmission through Actb-Flpe removed the Frt-Neo-Frt cassette. Actb-
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Flpe was subsequently removed by breeding. The mice are available at MMRRC,
Stock No.: 37511.
Plasmids. AAV-cTNT-Cre, AAV-U6gRNA-U6gRNA-cTNT-Cre, and AAV-
cTNT-GFP plasmids6,7,15 are available at Addgene.
To generate AAV-cTNT-GFP-version2, a 63 bp multiple cloning site was
synthesized as single-stranded oligos, annealed, and inserted into AAV-cTNT-GFP
through NheI and NcoI sites. Next, 3XHA-P2A sequence was synthesized (IDT)
and inserted into AAV-cTNT-GFP-version2 through NheI and NcoI sites to
generate AAV-cTNT-3XHA-P2A-GFP. Cre coding sequence was PCR-ampliﬁed
from AAV-cTNT-Cre and inserted into AAV-cTNT-3XHA-P2A-GFP through
NheI and SacI sites to generate AAV-cTNT-Cre-P2A-GFP. To generate AAV-
cTNT-SRF-P2A-GFP, Srf cDNA was purchased from GE Healthcare Dharmacon
Inc. (# MMM1013-202798340), ampliﬁed by PCR, and inserted into AAV-cTNT-
GFP-version2 plasmid at NheI and SpeI sites. The new plasmids will be available at
Addgene.
For CASAAV-mediated gene depletion, we designed 1–2 gRNAs per target gene
using the GPP Web Portal (Broad Institute). The gRNA sequences were
synthesized as single-stranded oligos, annealed, and inserted into AAV-U6gRNA-
U6gRNA-cTNT-Cre plasmids6,7 at SapI and/or AarI sites. gRNA sequences that
were used in this study are summarized in Supplementary Table 1.
AAV production and injection. One hundred and forty micrograms of AAV-ITR,
140 µg AAV9-Rep/Cap, and 320 µg pHelper (pAd-deltaF6, Penn Vector Core)
plasmids were produced by Maxiprep (Invitrogen, K210017) and transfected into
10 15-cm plates of HEK293T cells using PEI transfection reagent (Polysciences,
23966-2). Sixty hours after transfection, cells were scraped off of plates, resus-
pended in lysis buffer (20 mM Tris, pH 8, 150 mM NaCl, 1 mM MgCl2, 50 µg/ml
benzonase) and lysed by three freeze-thaw cycles. AAV in cell culture medium was
precipitated by PEG 8000 (VWR, 97061-100), resuspended in lysis buffer, and
pooled with cell lysates. AAV was puriﬁed in a density gradient (Cosmo Bio USA,
AXS-1114542) by ultracentrifugation (Beckman, XL-90) with a VTi-50 rotor and
concentrated in phosphate-buffered saline (PBS) with 0.001% pluronic F68 (Invi-
trogen, 24040032) using a 100 kDa ﬁlter tube (Fisher Scientiﬁc, UFC910024). AAV
titer was quantiﬁed by qPCR (primer sequences in Supplementary Table 2) using a
fragment of the TNT promoter DNA to make a standard curve.
AAV was injected into P1 pups subcutaneously. The P1 pups were anesthetized
in an isoﬂurane chamber before injection. Intraperitoneal injection was performed
to inject AAV into adult animals. AAV dosage was normalized based on body
weight at both neonatal and adult stages. In total, 5 × 108 viral genome per gram
body weight (vg g−1) was used in all mosaic analyses in this study. High and
intermediate doses corresponded to 1 × 1010 vg g−1 and 5 × 109 vg g−1,
respectively.
Echocardiography. Echocardiography was performed on a VisualSonics Vevo
2100 machine with the Vevostrain software. Animals were awake during this
procedure and held in a standard handgrip. The echocardiographer was blinded to
genotype and treatment.
Histology. After animals were euthanized by CO2. Hearts were harvested imme-
diately and ﬁxed by 4% paraformaldehyde overnight at 4 °C. Fixed hearts were
cryoprotected by soaking in 15% sucrose followed by 30% sucrose at 4 °C. Hearts
were embedded in tissue freezing medium (General Data, TFM-5). Ten micro-
meters of cryo-sections were cut using a cryostat (Thermo Scientiﬁc, Microm HM
550).
For Fast Green and Sirus Red staining, the frozen sections were washed with
PBS for 5 min, ﬁxed with pre-warmed Bouin’s solution (Sigma, HT10132) at 55 °C
for 1 h, and washed in running water. The sections were next stained with 0.1%
Fast Green (Millipore, 1040220025) for 10 min, washed with 1% acetic acid for
2 min, and rinsed with running water for 1 min. The sections were next stained
with 0.1% Sirus Red (Sigma, 365548) for 30 min and washed with running water
for 1 min. The slides were treated with 95% ethanol once for 5 min, twice with
100% ethanol for 5 min, and twice in xylene for 5 min before being mounted with
Permount (Fisher Scientiﬁc, SP15-500). Bright-ﬁeld images of stained tissue
sections were taken under a dissection microscope (Zeiss, SteREO Discovery V8).
In situ confocal imaging. In situ T-tubule imaging was performed as previously
described6,10. In brief, hearts were dissected from euthanized animals and can-
nulated on a Langendorff apparatus. FM 4–64 (2 µg/ml) (Invitrogen, 13320) was
diluted in perfusion buffer (10 mM HEPES (pH 7.4), 120.4 mM NaCl, 14.7 mM
KCl, 0.6 mM KH2PO4, 0.6 mM Na2HPO4, 1.2 mM MgSO4, 4.6 mM NaHCO3, 30
mM taurine, 10 mM 2,3-butanedione monoxime, 5.5 mM glucose) and loaded into
the heart by retrograde perfusion at room temperature for 10 min. The heart was
next removed from the perfusion system, positioned on a glass-bottom dish, and
immediately imaged on an inverted confocal microscope (Olympus FV1000).
In situ mitochondria imaging was performed by loading both 2 nM TMRM
(mitochondrial marker) and 2 µg/ml FM 4–64 (cell membrane marker) into the
heart by retrograde perfusion at room temperature for 10 min. The heart was
imaged on an inverted confocal microscope (Olympus FV1000).
CM isolation. CMs were isolated by retrograde collagenase perfusion using an
established protocol54. In brief, heparin-injected mice were anesthetized in an
isoﬂurane chamber. Hearts were isolated and cannulated onto a Langendorff
perfusion apparatus. Perfusion buffer (at 37 °C) was ﬁrst pumped into the heart to
ﬂush out blood and equilibrate the heart. Collagenase II (Worthington, LS004177)
was next perfused into the heart for 10 min at 37 °C to dissociate CMs. Heart apex
was cut from the digested heart, gently dissociated into single CMs in 10% fetal
bovine serum (FBS)/perfusion buffer, and ﬁltered through a 100 µm cell strainer to
remove undigested tissues.
Immunoﬂuorescence. To prepare cells for immunoﬂuorescence, the isolated CMs
were concentrated by 20 × g centrifugation for 5 min and resuspended in the cell
culture medium (Dulbecco's modiﬁed Eagle's medium (Gibco), 10% FBS, pen/strep
(Gibco), 10 µM blebbistatin). CMs were cultured on laminin-coated coverslips for
~40 min at 37 °C with 5% CO2 to allow cells to attach to the coverslips.
Next, immunoﬂuorescence was performed following published
protocols6,7,55,56. In brief, CMs were ﬁxed on coverslips by 4% paraformaldehyde
for 10–20 min, permeabilized by 0.1% Triton-100/PBS for 10 min, and blocked in
4% bovine serum albumin/PBS (blocking buffer) at 4 °C overnight. Then, the cells
were incubated with primary antibodies diluted in blocking buffer overnight at
4 °C. After washes with blocking buffer, the cells were incubated with secondary
antibodies and dyes at room temperature for 2 h. The cells were next washed with
PBS and mounted with ProLong Diamond antifade mountant (Invitrogen, 36961)
before imaging. All antibodies and dyes are listed in Supplementary Tables 3 and 4.
TUNEL staining was performed using In Situ Cell Death Detection Kit (Roche
Diagnostics, #11684795910) following the manufacturer’s instruction.
Fluorescence imaging and analysis. Confocal ﬂuorescence images were taken
using Olympus FV1000 inverted laser scanning confocal microscope equipped with
a ×60/1.3 silicone-oil objective. Fluorescence intensity was measured using ImageJ.
AutoTT9 was used to quantify T-tubule and sarcomere organization. Total TT
elements refer to the sum of longitudinal and transverse T-tubule elements. Cell
size and shape was manually measured on maximally projected images.
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Fig. 9 Schematic summary of SRF regulation of CM maturation. A balanced
level of SRF activity is required in maturing CMs for the transcription of
major genes that are required for CM maturation. These genes include
those that regulate mitochondria and metabolism, sarcomere assembly,
and ion channels. Among these genes, sarcomere genes are particularly
critical for organizing not only myoﬁbrils but also other aspects of
morphological maturation, such as mitochondria remodeling, maturational
hypertrophy, and T-tubule formation. These coordinated transcriptional and
morphological maturation events collectively establish the robust functions
of adult CMs, which is maintained throughout the animal’s lifespan
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Contractility assay and calcium imaging. Before contractility and calcium ana-
lyses, calcium was re-introduced into isolated CMs by treating cells with a series
of 10 ml 2,3-butanedione monoxim-free perfusion buffers containing 100 µM,
400 µM, 900 µM, and 1.2 mM CaCl2. At each step, CMs were allowed to settle by
gravity for 10 min at room temperature before being transferred to the next buffer
with higher calcium concentration.
For contractility assay, CMs were ﬁrst settled in laminin-coated 6-well dishes at
30 °C for 10 min. FP− and FP+ cells were identiﬁed and imaged through
epiﬂuorescence microscope. Next, CMs were electrically stimulated at 1 Hz and cell
contraction was recorded in the bright-ﬁeld channel of a Keyence BZ-X700
microscope at 33 fps using a ×40 objective. SarcOptiM were used to quantify
sarcomere shortening during contraction18.
For calcium imaging, CMs were loaded with 5 µM Fluo-4 (when FP reporter is
Tomato) or Rhod-2 (when FP reporter is Cas9GFP) for 20 min. The cells were next
washed with normal Tyrode solution (140 mM NaCl, 4 mM KCl, 1 mM MgCl2,
1.8 mM CaCl2, 10 mM glucose, 5 mM HEPES, pH= 7.4, adjusted with NaOH) for
20 min. The cells were next settled in a laminin-coated glass-bottom ﬂow chamber
at 30 °C for 10 min and electrically stimulated at 1 Hz to produce steady-state
conditions. Calcium signals were next acquired through confocal line scanning
using a ×60 objective. Line scan was positioned along the long axis of the cell in the
cytosol, avoiding the nuclear area. Calcium signal was quantiﬁed manually using
ImageJ.
EM analysis after FACS. EM analysis after FACS (FACS-EM) was performed as
follows. Isolated CMs in suspension were ﬁxed with 4% paraformaldehyde for 30
min at room temperature. The ﬁxed cells were next ﬁltered by passing through a
100 µm cell strainer, pelleted by centrifugation at 20 × g for 5 min at room tem-
perature, and resuspended in ~1 ml perfusion buffer. FACS was performed using a
BD Aria II SORP cell sorter with a 100 µm nozzle. After FACS, the cells were ﬁxed
again in a mixture of 2% formaldehyde and 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer, pH 7.4, overnight at 4 °C. The cell pellets were next processed
through a routine transmission EM (TEM) protocol at Harvard Medical School
EM core. Images were taken using a JEOL 1200EX-80 kV EM. Because of the cell
size and stiffness, ﬁxed adult CMs easily clogged the FACS machine. Currently,
FACS-EM only works for CMs from P30 and younger mice.
Reverse transcription-quantitative PCR analysis. For regular RT-qPCR analysis,
total RNA was puriﬁed using PureLink RNA Mini Kit (Ambion, 12183025).
Genomic DNA removal and reverse transcription was performed using Quanti-
Tech Reverse Transcription Kit (Qiagen, 205311). Real-time PCR was performed
using an ABI 7500 thermocycler with Power SYBR Green PCR Kit (Thermo Fisher,
4368702). QPCR primers are listed in Supplementary Table 2.
For FACS-RT-qPCR, isolated CMs were ﬁltered with a 100 µm cell strainer,
pelleted by centrifugation at 20 × g for 5 min and resuspended in ~1 ml cold
perfusion buffer. FACS were performed using a BD Aria II SORP cell sorter with a
100 µm nozzle and a sample collection cooling device. Immediately after FACS,
cells were centrifuged at 13,000 rpm at 4 °C to remove supernatant. Total RNA was
puriﬁed using PureLink RNA Micro Kit (Thermo Fisher, 12183016) and genome
DNA removed by on-column DNase I digestion. RT was performed using
SuperScript III Kit (Thermo Fisher), or SMART-Seq v4 Ultra Low Input RNA Kit
(Clontech) if RNA yield was too low to be detected by regular RT-qPCR. Real-time
PCR was performed using an ABI 7500 thermocycler using Taqman probes listed
in Supplementary Table 5.
Western blot analysis after FACS. FACS-sorted CMs were lysed in 2× sodium
dodecyl sulfate sample buffer at 1000 cell/µl to normalize protein content. After
boiling for 5 min, 5 µl cell lysate of each sample was separated on a 4–12% gradient
gel (Invitrogen, Bolt gels, NW04122BOX), transferred to a polyvinylidene
diﬂuoride membrane, and blocked by 4% milk/TBST (Tris-buffered saline, 0.1%
Tween-20). Primary antibodies were incubated with the membrane overnight at 4 °
C, followed by four 15 min TBST washes. Horse radish peroxidase (HRP)-con-
jugated secondary antibodies were probed for 1–2 h at room temperature, followed
by four 15 min TBST washes. After adding Immobilon Western Chemiluminescent
HRP Substrate (Millipore, WBKLS0500), chemiluminescence were detected by a
Li-Cor C-DiGit blot scanner. Antibodies used in this study are listed in Supple-
mentary Table 3. All uncropped western blots can be found in Supplementary
Fig. 9.
RNA-seq and data analysis. FACS-sorted CMs were centrifuged at 10,000 × g for 1
min and supernatant ﬂuids were removed. Total RNA was extracted using PureLink
RNA Micro Kit (Thermo Fisher, 12183016) with genome DNA removed through on-
column DNase I digestion. Ten nanograms of total RNA was reverse transcribed and
full-length cDNA was speciﬁcally ampliﬁed by eight PCR cycles using SMART-Seq v4
Ultra Low Input RNA Kit (Clontech)19. RNA-seq libraries were constructed using
Illumina’s Nextera XT Kit and single-ended reads were sequenced using NextSeq
500 sequencer at Harvard Medical School biopolymers facility.
RNA-seq reads were aligned to mm10 by STAR57 and reads counts were
calculated by FeatureCounts58. DESeq2 was next used to perform statistical
analysis of differential gene expression59. An adjusted P value of 0.05 was used as
cutoff to identify differentially regulated genes. GSEA analysis with ranked gene
lists was used to perform GO term analysis60. IPA (Qiagen Inc.) was used for
upstream regulator network analysis61.
BioChIP-Seq and data analysis. For each biological replicate, four heart ventricles
were collected from two male and two female P14 Srffbio/+;Rosa26birA/+ mice and
minced in 1% formaldehyde-containing PBS at room temperature by a motor-driven
homogenizer (IKA T10 basic). The tissue suspension was shaken for 15min at room
temperature for crosslinking. Glycine was added to ﬁnal concentration of 125mM to
quench formaldehyde. Chromatin isolation was performed as previously described62.
A microtip sonicator (QSONICA Q700) was used at 60% amplitude and a cycle of 5 s
on and 20 s off for 96 cycles in total. Sheared chromatin was precleared by incubation
with 100 µl Dynabeads Protein A (Life Technologies, 10002D) for 1 h at 4 °C. The
precleaned chromatin was then incubated with 100 µl Dynabeads M-280 Streptavidin
(Life Technologies, 11206D) for 1 h at 4 °C. The streptavidin beads were washed and
bound DNA eluted62. BioChIP DNA was puriﬁed with MinElute PCR Puriﬁcation
Kit (Qiagen, 28006). ChIP-seq libraries were constructed using a ChIP-seq Library
Preparation Kit (KAPA Biosystems, KK8500). Fifty nanograms of sonicated chro-
matin without pull-down was used as input.
Single-end sequencing (75 nt) was performed on a NextSeq 500 sequencer.
Reads were aligned to mm10 using Bowtie 263 using default parameters. Peaks were
called with MACS264 against input chromatin background. Murine blacklist
regions were masked out of peak lists. Homer (http://homer.ucsd.edu/homer/) was
used to annotate peaks to the nearest gene and to perform motif analysis65.
DeepTools was used to generate aggregation and heatmap plots66. bioChIP-seq
signal was visualized in the Integrated Genome Viewer67.
Data availability
The authors declare that all data supporting the ﬁndings of this study are available within
the article and its Supplementary information ﬁles or from the corresponding author
upon reasonable request. RNA-seq and ChIP-seq data have been deposited in the Gene
Expression Omnibus (GEO) database under the accession codes: GSE109425 (for the Srf
KO RNA-seq), GSE109504 (ChIP-seq), and GSE116030 (for the Srf OE RNA-seq). The
data are also available on the Cardiovascular Development Consortium server (https://
b2b.hci.utah.edu/gnomex) (sign in as guest).
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